Dr. Ng Su-Peing, global medical head at Sanofi Pasteur, the manufacturer of dengue vaccine Dengvaxia, speaks at a news conference in suburban Taguig city, east of Manila, Philippines Monday, Dec. 4, 2017. The manufacturer of the dengue vaccine whose use was suspended by the Philippines last week after a study showed risks of severe cases in people without previous infection says it is working to resolve those fears. (AP Photo/Bullit Marquez)
Featured Photo Galleries
